Kozlov L V
G.N. Gabrichevsky Moscow Scientific Research Institute of Epidemiology and Microbiology, 125212 Moscow, Street of Admiral Makarova.
Vopr Med Khim. 2002 Nov-Dec;48(6):624-31.
Development suitable for clinical researches of hemolytic methods of determination of functional activity of the first components of a complement has allowed to show diagnostic value of testing activity of complement components in comparison with their contents as antigens. It has predetermined necessity for building modern ELISA tests-systems for quantitative determination of functional activity of complement components. Such methods built for the first time allow to determine activity of components C1q, C2, C3, C4 (and a ratio of isotypes C4A and C4B), C1-inhibitor, factors B and D. Addition of these tests-systems ELISA systems for quantitative determination of components, and in case of C1-inhibitor of presence IgG, IgA and IgM autoantibodies against C1-inhibitor frames opportunities of an evaluation complement status of the patient, hereditary predisposition to such diseases as a stomach ulcer, the glaucoma, a clamidiosis, bacteroidosis, allows to carry out differential diagnostics of angioedema. Inhibition of covalent linkage C4b or C3b various endogenic and exogenous effectors during formation C3- and C5-convertases allows to understand processes of a regulation of a homeostasis, and also the mechanism of action of drugs.
适用于补体第一成分功能活性溶血测定法临床研究的发展,已能显示出与补体成分作为抗原的含量相比,检测补体成分活性的诊断价值。这就预先确定了构建用于定量测定补体成分功能活性的现代酶联免疫吸附测定(ELISA)检测系统的必要性。首次构建的此类方法能够测定C1q、C2、C3、C4(以及同种型C4A和C4B的比例)、C1抑制物、B因子和D因子的活性。这些ELISA检测系统用于定量测定补体成分,并且在C1抑制物存在针对C1抑制物的IgG、IgA和IgM自身抗体的情况下,为评估患者的补体状态、对诸如胃溃疡、青光眼、衣原体病、类杆菌病等疾病的遗传易感性提供了机会,有助于对血管性水肿进行鉴别诊断。在形成C3和C5转化酶过程中,各种内源性和外源性效应物对C4b或C3b共价键的抑制作用,有助于理解内环境稳定的调节过程以及药物的作用机制。